Breast cancer is the most common malignancy among women worldwide, with increasing incidence especially in younger populations1. Early detection through regular mammograms starting at age 40 is critical to identifying tumors when they are more manageable and improving survival outcomes23. Former MTV VJ Ananda Lewis was diagnosed with stage III breast cancer but chose to forgo the recommended double mastectomy, opting instead for alternative treatments; her cancer deaths later progressed to stage IV45. Her case highlights the complex decisions patients face and the crucial role surgery plays in breast cancer treatment4.
Ananda Lewis’s case underscores the importance of early detection and adherence to recommended surgical treatment. Despite integrative therapies and lifestyle changes, her cancer progressed to an incurable stage after declining surgery. This highlights the critical role of surgery in achieving long-term survival for breast cancer patients214.
Double Mastectomy Procedure and Recommendations
A double mastectomy, also known as bilateral mastectomy, is a surgical procedure that removes both breasts to treat or prevent breast cancer6. This procedure is often recommended in specific clinical scenarios, such as when cancer is present in both breasts simultaneously or when patients carry high-risk genetic mutations like BRCA1 or BRCA2789. These mutations confer a lifetime breast cancer risk estimated between 60% and 80%, making prophylactic bilateral mastectomy a preventive option to significantly reduce cancer incidence1112.
Surgical removal of the tumor remains a cornerstone of curative treatment for early-stage breast cancer, particularly stages I through III1314. The choice between mastectomy and breast-conserving surgery, such as lumpectomy, depends on factors including tumor size, tumor location, and breast size15. A single mastectomy removes only the affected breast, while a lumpectomy removes the tumor and some surrounding tissue, preserving most of the breast1. Some patients also opt for bilateral mastectomy for cosmetic symmetry or to alleviate anxiety about future cancer risk16.
Ananda Lewis was diagnosed with stage III breast cancer in January 2019, with a tumor growing at a moderate rate and lymph node involvement17. Her doctors recommended a double mastectomy as part of the standard treatment approach. However, Lewis chose to keep her tumor and pursue integrative health methods, including radiation, dietary changes, and homeopathic therapies417. Despite some tumor reduction after treatment, her cancer eventually spread beyond the original site, advancing to stage IV17.
- Presence of synchronous tumors in both breasts requiring bilateral removal8
- High genetic risk due to BRCA1 or BRCA2 mutations, with prophylactic intent91011
- Large tumor size or unfavorable tumor location making breast conservation impractical15
- Patient preference for symmetry or anxiety reduction regarding future cancer risk16
- Cases where cancer has already spread to both breasts (bilateral breast cancer)7
Risks of Refusing Breast Cancer Surgery
Declining surgical treatment for breast cancer is associated with significantly poorer survival outcomes and an increased risk of disease progression and metastasis1819. Surgery remains the best-established curative option for stages I to III breast cancer, aiming to achieve local control of the tumor and improve long-term survival1314. Without surgery, breast cancer can spread to other parts of the body regardless of subtype, ultimately becoming metastatic and incurable20.
Ananda Lewis’s decision to refuse the recommended double mastectomy exemplifies these risks. After opting for alternative treatments such as homeopathic remedies, radiation, and lifestyle changes, her cancer progressed from stage III to stage IV, spreading beyond the lymph nodes421. She later expressed regret over not having undergone surgery, acknowledging it as a mistake22.
“The absence of detectable breast cancer recurrences at the five-year mark highlights the tremendous potential of this surgery-free approach to breast cancer management.”
— Dr. Henry Kuerer, The University of Texas MD Anderson Cancer Center26
Women who refuse surgery for breast cancer have a lower five-year survival rate and a higher risk of dying from the disease184. Studies show that patients who decline at least some recommended treatments, including surgery, chemotherapy, or radiation, face significantly increased mortality risks3. Despite this, some patients choose alternative therapies due to fear of side effects, distrust of the medical system, or a desire for control over their care323.
Early detection through regular mammography screening starting at age 40 is critical for identifying breast cancer at a stage when surgery and other treatments are most effective23. Delays in screening can lead to later-stage diagnosis and worse prognosis24. Common symptoms that should prompt medical evaluation include breast lumps, skin dimpling, nipple changes, rash around the nipple, rapid breast swelling, and nipple discharge25.
- Increased risk of cancer progression and metastasis1920
- Lower five-year survival rates and higher mortality184
- Loss of opportunity for curative treatment in early-stage disease1314
- Potential for cancer to spread to lymph nodes and distant organs421
- Psychological impact and increased anxiety due to uncontrolled disease1623
While surgery is standard for most early-stage breast cancers, emerging research suggests that in very select cases, surgery might be safely omitted if tumors completely disappear after chemotherapy. A small study of 31 patients with small, invasive HER2-positive or triple-negative breast cancers who had no residual tumor after chemotherapy received radiation but no surgery, and all were alive without recurrence after five years26. However, this approach is experimental and requires further clinical trials before becoming standard practice.
